Abbott Laboratories's Revenue by Region
In fiscal year 2025, Abbott Laboratories's revenue by geographical region are as follows:
- C [H]: $1.87 B
- C [N]: $1.91 B
- D [E]: $2.76 B
- I [N]: $1.87 B
- J [P]: $1.48 B
- Non-US: $15.98 B
- UNITED STATES: $17.13 B
Learn more about Abbott Laboratories’s Revenue by Products
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
Abbott Laboratories's Revenue Share by Region
| C [H] | 1638000000 |
|---|---|
| C [N] | 2253000000 |
| D [E] | 2345000000 |
| I [N] | 1750000000 |
| J [P] | 1513000000 |
| N [L] | 1074000000 |
| Non-US | 14084000000 |
| UNITED STATES | 15452000000 |
| C [H] | 1747000000 |
|---|---|
| C [N] | 2113000000 |
| D [E] | 2539000000 |
| I [N] | 1817000000 |
| J [P] | 1441000000 |
| N [L] | 1124000000 |
| Non-US | 14846000000 |
| UNITED STATES | 16323000000 |
| C [H] | 1871000000 |
|---|---|
| C [N] | 1907000000 |
| D [E] | 2759000000 |
| I [N] | 1871000000 |
| J [P] | 1475000000 |
| Non-US | 15979000000 |
| UNITED STATES | 17126000000 |
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2023, Abbott Laboratories's revenue by region is as follows:
- C [H] generated $1.64 B in revenue, representing 4.08% of its total revenue.
- C [N] generated $2.25 B in revenue, representing 5.62% of its total revenue.
- D [E] generated $2.35 B in revenue, representing 5.85% of its total revenue.
- I [N] generated $1.75 B in revenue, representing 4.36% of its total revenue.
- J [P] generated $1.51 B in revenue, representing 3.77% of its total revenue.
- N [L] generated $1.07 B in revenue, representing 2.68% of its total revenue.
- Non-US generated $14.08 B in revenue, representing 35.11% of its total revenue.
- UNITED STATES generated $15.45 B in revenue, representing 38.53% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 38.53% of its total revenue.
The smallest region for Abbott Laboratories is the N [L], which represents 2.68% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2024, Abbott Laboratories's revenue by region is as follows:
- C [H] generated $1.75 B in revenue, representing 4.16% of its total revenue.
- C [N] generated $2.11 B in revenue, representing 5.04% of its total revenue.
- D [E] generated $2.54 B in revenue, representing 6.05% of its total revenue.
- I [N] generated $1.82 B in revenue, representing 4.33% of its total revenue.
- J [P] generated $1.44 B in revenue, representing 3.44% of its total revenue.
- N [L] generated $1.12 B in revenue, representing 2.68% of its total revenue.
- Non-US generated $14.85 B in revenue, representing 35.39% of its total revenue.
- UNITED STATES generated $16.32 B in revenue, representing 38.91% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 38.91% of its total revenue.
The smallest region for Abbott Laboratories is the N [L], which represents 2.68% of its total revenue.
The above chart shows Abbott Laboratories's revenue percentage share by geographical region.
In fiscal year 2025, Abbott Laboratories's revenue by region is as follows:
- C [H] generated $1.87 B in revenue, representing 4.35% of its total revenue.
- C [N] generated $1.91 B in revenue, representing 4.44% of its total revenue.
- D [E] generated $2.76 B in revenue, representing 6.42% of its total revenue.
- I [N] generated $1.87 B in revenue, representing 4.35% of its total revenue.
- J [P] generated $1.48 B in revenue, representing 3.43% of its total revenue.
- Non-US generated $15.98 B in revenue, representing 37.17% of its total revenue.
- UNITED STATES generated $17.13 B in revenue, representing 39.84% of its total revenue.
The biggest region for Abbott Laboratories is the UNITED STATES, which represents 39.84% of its total revenue.
The smallest region for Abbott Laboratories is the J [P], which represents 3.43% of its total revenue.
Summary Table
| Geography (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| C [H] | 4.08% | 4.16% | 4.35% |
| C [N] | 5.62% | 5.04% | 4.44% |
| D [E] | 5.85% | 6.05% | 6.42% |
| I [N] | 4.36% | 4.33% | 4.35% |
| J [P] | 3.77% | 3.44% | 3.43% |
| N [L] | 2.68% | 2.68% | 0% |
| Non-US | 35.11% | 35.39% | 37.17% |
| UNITED STATES | 38.53% | 38.91% | 39.84% |
| Total Revenue | 100% | 100% | 100% |
Abbott Laboratories's Regions Revenue Trend
The above chart shows the revenue trend of different segments of Abbott Laboratories.
In fiscal year 2025, the UNITED STATES generated the most revenue ($17.13 B), and the J [P] generated the least revenue ($1.48 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Region | 2023 | 2024 | 2025 |
|---|---|---|---|
| C [H] | $1.64 B - |
$1.75 B
6.65%
|
$1.87 B
7.10%
|
| C [N] | $2.25 B - |
$2.11 B
6.21%
|
$1.91 B
9.75%
|
| D [E] | $2.35 B - |
$2.54 B
8.27%
|
$2.76 B
8.66%
|
| I [N] | $1.75 B - |
$1.82 B
3.83%
|
$1.87 B
2.97%
|
| J [P] | $1.51 B - |
$1.44 B
4.76%
|
$1.48 B
2.36%
|
| N [L] | $1.07 B - |
$1.12 B
4.66%
|
- - |
| Non-US | $14.08 B - |
$14.85 B
5.41%
|
$15.98 B
7.63%
|
| UNITED STATES | $15.45 B - |
$16.32 B
5.64%
|
$17.13 B
4.92%
|
| Total Revenue | $40.11 B - |
$41.95 B
4.59%
|
$42.99 B
2.47%
|
Related
-
Agilent Technologies Revenue by Region
-
Eli Lilly and Company Revenue by Region
-
Stryker Corporation Revenue by Region
-
Johnson & Johnson Revenue by Region
-
AbbVie Revenue by Region
-
Merck & Co. Revenue by Region
-
Thermo Fisher Scientific Revenue by Region
-
Danaher Corporation Revenue by Region
-
Amgen Revenue by Region
-
Pfizer Revenue by Region
